CNNC Atom High-Tech Sodium Iodide Capsules Supplied Directly to Macao for the First Time

Recently, sodium iodide [¹³¹I] capsules independently developed and produced by Atom High-Tech Co., Ltd., a subsidiary of China Isotope & Radiation Corporation under CNNC, successfully arrived at clinical frontlines in Macao, achieving the first stable supply of domestically produced sodium iodide [¹³¹I] capsules to Macao and completely filling the previous gap in Macao's lack of this clinical diagnostic and therapeutic service.

It is understood that sodium iodide [¹³¹I] capsules are core radiopharmaceuticals widely used clinically for the diagnosis and treatment of thyroid diseases. Previously, Atom High-Tech had successfully achieved routine supply of short-half-life radiopharmaceuticals to Macao; the successful launch of this new product will strongly support Macao medical institutions in carrying out systematic radionuclide therapy and effectively reduce the burden of cross-border medical treatment on local patients.

During the project advancement, Atom High-Tech strictly aligned with local Macao regulations and clinical needs, comprehensively accelerating the internationalization upgrade and regulatory compliance access of its products. All teams of the company collaborated efficiently to ensure the safe, professional and high-quality operation of this cross-sea lifeline, once again setting the "acceleration" pace of China's nuclear medicine industry development.

The successful supply of domestically produced nuclear medicine to Macao this time marks a new step forward in standard mutual recognition and industrial integration between Guangdong and Macao in the field of nuclear medicine diagnosis and treatment. In the future, Atom High-Tech will continue to deepen all-round cooperation between the mainland and Hong Kong and Macao in clinical supply, technical collaboration and talent training, enabling residents of the Greater Bay Area to share more convenient and reassuring nuclear medicine health services.